Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Leo Meriranta"'
Autor:
Kathrine T. Isaksen, Klaus Beiske, Erlend B. Smeland, Judit Jørgensen, Marianne Brodtkorb, June Helen Myklebust, Mats Jerkeman, Leo Meriranta, Marja‐Liisa Karjalainen‐Lindsberg, Sirpa Leppä, David W. Scott, Harald Holte, Yngvild Nuvin Blaker
Publikováno v:
eJHaem, Vol 2, Iss 1, Pp 104-108 (2021)
Externí odkaz:
https://doaj.org/article/065690fb5d4347f098331a06996ed6e6
Autor:
Leo Meriranta, Annika Pasanen, Riku Louhimo, Alejandra Cervera, Amjad Alkodsi, Matias Autio, Minna Taskinen, Ville Rantanen, Marja-Liisa Karjalainen-Lindsberg, Harald Holte, Jan Delabie, Rainer Lehtonen, Sampsa Hautaniemi, Sirpa Leppä
Publikováno v:
Haematologica, Vol 102, Iss 5 (2017)
Externí odkaz:
https://doaj.org/article/28cc657606594d109e90f141258ab1de
Autor:
Leo Meriranta, Amjad Alkodsi, Annika Pasanen, Maija Lepistö, Parisa Mapar, Yngvild Nuvin Blaker, Judit Jørgensen, Marja-Liisa Karjalainen-Lindsberg, Idun Fiskvik, Lars Tore G. Mikalsen, Matias Autio, Magnus Björkholm, Mats Jerkeman, Øystein Fluge, Peter Brown, Sirkku Jyrkkiö, Harald Holte, Esa Pitkänen, Pekka Ellonen, Sirpa Leppä
Publikováno v:
Blood
Meriranta, L, Alkodsi, A, Pasanen, A, Lepistö, M, Mapar, P, Blaker, Y N, Jørgensen, J M, Karjalainen-Lindsberg, M-L, Fiskvik, I, Mikalsen, L T G, Autio, M, Björkholm, M, Jerkeman, M, Fluge, Ø, Brown, P, Jyrkkiö, S, Holte, H, Pitkänen, E, Ellonen, P & Leppa, S 2022, ' Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma ', Blood, vol. 139, no. 12, pp. 1863-1877 . https://doi.org/10.1182/blood.2021012852
Meriranta, L, Alkodsi, A, Pasanen, A, Lepistö, M, Mapar, P, Blaker, Y N, Jørgensen, J M, Karjalainen-Lindsberg, M-L, Fiskvik, I, Mikalsen, L T G, Autio, M, Björkholm, M, Jerkeman, M, Fluge, Ø, Brown, P, Jyrkkiö, S, Holte, H, Pitkänen, E, Ellonen, P & Leppa, S 2022, ' Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma ', Blood, vol. 139, no. 12, pp. 1863-1877 . https://doi.org/10.1182/blood.2021012852
Inadequate molecular and clinical stratification of the patients with high-risk diffuse large B-cell lymphoma (DLBCL) is a clinical challenge hampering the establishment of personalized therapeutic options. We studied the translational significance o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43a8922736ebf9763275c471d8a04f16
https://doi.org/10.1182/blood.2021012852
https://doi.org/10.1182/blood.2021012852
Autor:
Mats Jerkeman, Arne Kolstad, Martin Hutchings, Annika Pasanen, Leo Meriranta, Carsten Utoft Niemann, Rasmus Rask Kragh Jørgensen, Tarec Christoffer Christoffer El-Galaly, Jon Riise, Sirpa Leppä, Jacob Haaber Christensen, Karin Fahl Wader, Ingrid Glimelius
Publikováno v:
Jerkeman, M, Kolstad, A, Hutchings, M, Pasanen, A, Meriranta, L, Niemann, C U, Jorgensen, R R K, El-Galaly, T C C, Riise, J, Leppä, S, Christensen, J H, Wader, K F & Glimelius, I 2022, ' Venetoclax, Lenalidomide and Rituximab for Patients with Relapsed or Refractory Mantle Cell Lymphoma-the Nordic Lymphoma Group NLG-MCL7 (VALERIA) Phase Ib-II Trial ', Blood, vol. 140, no. Suppl. 1, 623, pp. 184–185 . https://doi.org/10.1182/blood-2022-155654
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da1851415e30a6d0c9264d990029d0af
https://vbn.aau.dk/da/publications/bc6618eb-cade-4a63-9961-a4be4759051d
https://vbn.aau.dk/da/publications/bc6618eb-cade-4a63-9961-a4be4759051d
Autor:
David W. Scott, Kathrine T. Isaksen, Judit Jørgensen, Sirpa Leppä, Marja-Liisa Karjalainen-Lindsberg, June Helen Myklebust, Harald Holte, Marianne Brodtkorb, Yngvild Nuvin Blaker, Erlend B. Smeland, Klaus Beiske, Leo Meriranta, Mats Jerkeman
Publikováno v:
eJHaem. 2:104-108
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bf0834412b61953d1a565483ed6bbf9
https://doi.org/10.1002/jha2.109
https://doi.org/10.1002/jha2.109
Autor:
Leo Meriranta, Selma Sorri, Sadia Zafar, Xiaonan Liu, Eerika Sahlberg, Olli Dufva, Helka Göös, Marja-Liisa Karjalainen-Lindsberg, Markku Varjosalo, Marko Hyytiäinen, Sirpa Leppa
Publikováno v:
Blood. 140:5889-5890
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b2c31bb17d8f19e9a65ff3267bc97c9
https://doi.org/10.1182/blood-2022-166768
https://doi.org/10.1182/blood-2022-166768
Autor:
Sirpa Leppa, Judit M. Jørgensen, Marja-Liisa Karjalainen-Lindsberg, Klaus Beiske, Mette Pedersen, Kristina Drott, Annika Pasanen, Kristiina Karihtala, Susanna Mannisto, Leo Meriranta, Bente Wold, Marianne Brodtkorb, Unn Merete Fagerli, Thomas S. Larsen, Lars Munksgaard, Kaisa Sunela, Øystein Fluge, Sirkku Jyrkkio, Peter de Nully Brown, Harald Holte
Publikováno v:
Blood. 140:1768-1769
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1874a85a267c9a743ae74b5e0dfeebe
https://doi.org/10.1182/blood-2022-158183
https://doi.org/10.1182/blood-2022-158183
Autor:
Maare Arffman, Leo Meriranta, Harald Holte, Judit Jørgensen, Peter De Nully Brown, Sirkku Jyrkkio, Mats Jerkeman, Øystein Fluge, Magnus Björkholm, Matias Autio, Suvi-Katri Leivonen, Sirpa Leppa
Publikováno v:
Blood. 140:1316-1317
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f9730caa89ad17ccc287f25f8e29042
https://doi.org/10.1182/blood-2022-158426
https://doi.org/10.1182/blood-2022-158426
Autor:
Disha Malani, Satu Mustjoki, Olli Lohi, Matti Kankainen, Kirsi J. Granberg, Olli Dufva, Mikko A. I. Keränen, Markus Vähä-Koskela, Merja Heinäniemi, Bishwa Ghimire, Matti Nykter, Sirpa Leppä, Ashwini Kumar, Leo Meriranta, Pirkko Mattila, Petri Pölönen, Juha Mehtonen, Suvi-Katri Leivonen, Krister Wennerberg, Oscar Brück, Jay Klievink, Sanna Siitonen, Jani Huuhtanen, Caroline A. Heckman, Jenni Lahtela
Publikováno v:
Cancer Cell. 38:424-428
Understanding factors that shape the immune landscape across hematological malignancies is essential for immunotherapy development. We integrated over 8,000 transcriptomes and 2,000 samples with multilevel genomics of hematological cancers to investi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19ff4ee7a109e3a2aac727d48bd4b02f
https://doi.org/10.1016/j.ccell.2020.08.019
https://doi.org/10.1016/j.ccell.2020.08.019
Autor:
Leo Meriranta, Sirpa Leppä, Marja-Liisa Karjalainen-Lindsberg, Annika Pasanen, Amjad Alkodsi, Jari Haukka
Publikováno v:
Blood Adv
Concomitant deregulation of MYC and BCL2 comprises clinically significant, yet poorly characterized biological high-risk feature in diffuse large B-cell lymphoma (DLBCL). To interrogate these lymphomas, we analyzed translocations and protein expressi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5293694d85ec4fdb2af0b2158fa4ee0b
https://doi.org/10.1182/bloodadvances.2020001727
https://doi.org/10.1182/bloodadvances.2020001727